ATG10 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG101 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG101 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG12 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG13 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG14 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG16L1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG16L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG16L2 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG16L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG2A Human Pre-designed siRNA Set A contains three designed siRNAs for ATG2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG2B Human Pre-designed siRNA Set A contains three designed siRNAs for ATG2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG3 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG4A Human Pre-designed siRNA Set A contains three designed siRNAs for ATG4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG4B Human Pre-designed siRNA Set A contains three designed siRNAs for ATG4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG4C Human Pre-designed siRNA Set A contains three designed siRNAs for ATG4C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG4D Human Pre-designed siRNA Set A contains three designed siRNAs for ATG4D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG5 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG7 Human Pre-designed siRNA Set A contains three designed siRNAs for ATG7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG9A Human Pre-designed siRNA Set A contains three designed siRNAs for ATG9A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATG9B Human Pre-designed siRNA Set A contains three designed siRNAs for ATG9B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATIC Human Pre-designed siRNA Set A contains three designed siRNAs for ATIC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Atigliflozin (AVE-2268) is an orally active and selective SGLT-2 inhibitor, with IC50s of 10 nM and 8.2 μM for hSGLT-2 and hSGLT-1) respectively. Atigliflozin can lower the blood glucose and improve the impaired oral glucose tolerance. Atigliflozin can be used for research of type II diabetes mellitus[1].

ATL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ATL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ATL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATM Human Pre-designed siRNA Set A contains three designed siRNAs for ATM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Atm Mouse Pre-designed siRNA Set A contains three designed siRNAs for Atm gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Atm Rat Pre-designed siRNA Set A contains three designed siRNAs for Atm gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATMIN Human Pre-designed siRNA Set A contains three designed siRNAs for ATMIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATN1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATOH1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATOH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATOH7 Human Pre-designed siRNA Set A contains three designed siRNAs for ATOH7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATOH8 Human Pre-designed siRNA Set A contains three designed siRNAs for ATOH8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Atorvastatin acetonide tert-butyl ester (Standard) is the analytical standard of Atorvastatin acetonide tert-butyl ester. This product is intended for research and analytical applications. Atorvastatin acetonide tert-butyl ester is a useful pharmaceutical intermediate in the preparation of Atorvastatin salts. Atorvastatin is an orally active HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids[1].

Atorvastatin (hemicalcium salt) (Standard) is the analytical standard of Atorvastatin (hemicalcium salt). This product is intended for research and analytical applications. Atorvastatin hemicalcium salt (CI-981) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin hemicalcium salt inhibits human SV-SMC proliferation and invasion with IC50s of […]

ATOSA Human Pre-designed siRNA Set A contains three designed siRNAs for ATOSA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATOSB Human Pre-designed siRNA Set A contains three designed siRNAs for ATOSB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATOX1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATOX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP10A Human Pre-designed siRNA Set A contains three designed siRNAs for ATP10A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP10B Human Pre-designed siRNA Set A contains three designed siRNAs for ATP10B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP10D Human Pre-designed siRNA Set A contains three designed siRNAs for ATP10D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP11A Human Pre-designed siRNA Set A contains three designed siRNAs for ATP11A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP11B Human Pre-designed siRNA Set A contains three designed siRNAs for ATP11B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP12A Human Pre-designed siRNA Set A contains three designed siRNAs for ATP12A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP13A1 Human Pre-designed siRNA Set A contains three designed siRNAs for ATP13A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.